
Keywords: α-SMA; α-smooth muscle actin; Ad; adamantane; BMP-7; bone morphogenetic protein 7; CD; β-cyclodextrine; CKD; chronic kidney disease; CPP; cell penetrating peptide; COX-2; cyclooxygenase 2; CTGF; connective tissue growth factor; DAMPs; danger associated